2016
DOI: 10.1016/j.bbr.2016.03.052
|View full text |Cite
|
Sign up to set email alerts
|

Real-space path integration is impaired in Alzheimer’s disease and mild cognitive impairment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
33
0
4

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(42 citation statements)
references
References 43 publications
5
33
0
4
Order By: Relevance
“…The navigational impairments observed in MCI patients is in line with previous navigation research (Hort et al, 2007;Laczó et al, 2014;Peter et al, 2018) and with the sparse literature on real-space PI in MCI and AD (Mokrisova et al, 2016). Significantly larger absolute distance errors were observed in MCI+ than in MCI-, with near-total separation of these two groups on this primary outcome measure, with the latter group exhibiting comparable performance to HCs.…”
Section: !supporting
confidence: 88%
See 1 more Smart Citation
“…The navigational impairments observed in MCI patients is in line with previous navigation research (Hort et al, 2007;Laczó et al, 2014;Peter et al, 2018) and with the sparse literature on real-space PI in MCI and AD (Mokrisova et al, 2016). Significantly larger absolute distance errors were observed in MCI+ than in MCI-, with near-total separation of these two groups on this primary outcome measure, with the latter group exhibiting comparable performance to HCs.…”
Section: !supporting
confidence: 88%
“…Absolute distance error, the primary outcome measure, was defined as the Euclidean distance between estimated and actual location of cone one, in line with previous research (Fig. 2, Chrastil et al, 2015;Mokrisova et al, 2016). Two secondary outcome measures were included to deconstruct absolute distance errors into its proportional angular and linear components.…”
Section: !mentioning
confidence: 99%
“…Moreover, deficits in route learning performance in early AD have been associated with hypometabolism in the retrosplenial cortex, thalamus and parietal cortex (Pengas et al, 2012). Mokrisova et al (2016) showed that deficits in path integration in AD and MCI were mediated in part by changes in hippocampal, entorhinal and parietal cortex volumes. Cumulatively, these findings suggest that changes in the ‘navigation circuit’ may be a predominant and early consequence of AD and manifest as behavioral deficiencies in spatial navigation.…”
Section: Clinical Potential Of Spatial Navigationmentioning
confidence: 99%
“…AD patients show severe difficulty storing and retrieving a cognitive map of virtual environments (DeIpolyi et al, 2007;Jheng and Pai, 2009;Serino et al, 2015), consistent with significant cell loss in the hippocampus which is home to the place cells, the cellular building blocks of the human and rodent 'cognitive map' (Bird and Burgess, 2008;O'Keefe & Nadel, 1978). Navigation tests also show egocentric self-reference strategies are also lost in AD patients, due to various metabolic and volumetric changes that occur in the retrosplenial cortex, posterior cingulate cortex (PCC) and parietal cortex where head direction and border cells reside (Mokrisova et al, 2016;Pai and Yang, 2013;Pengas et al, 2010;Serino et al, 2015).…”
Section: Introductionmentioning
confidence: 76%
“…Gold standard episodic memory tests fail to capture the first symptomatic manifestation of AD (Coughlan et al, 2018b;Jessen et al, 2014;Zimermann et al, 2019) and therefore, alternative diagnostic tools are urgently required. Spatial navigation has emerged as a critical diagnostic tool in the clinical AD and mild cognitively impaired cohorts due to its sensitivity and specificity for AD pathophysiology (Hort et al, 2014(Hort et al, , 2007Howett et al, 2019;Laczó et al, 2009;Lester et al, 2017;Mokrisova et al, 2016;Pai and Jacobs, 2004;Serino and Riva, 2013;Tu et al, 2015;Vlček, K., & Laczó, 2014). For example, spatial navigation tasks, such as the Virtual Supermarket Test (VST) can distinguish AD from other dementias and have been implemented in many high-profile clinical trials as treatment outcome measures.…”
Section: Introductionmentioning
confidence: 99%